Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Oct;46(10):1833-1839.
doi: 10.1038/s41366-022-01182-4. Epub 2022 Jul 25.

Effects of a palaeolithic diet on obstructive sleep apnoea occurring in females who are overweight after menopause-a randomised controlled trial

Affiliations
Randomized Controlled Trial

Effects of a palaeolithic diet on obstructive sleep apnoea occurring in females who are overweight after menopause-a randomised controlled trial

Karl A Franklin et al. Int J Obes (Lond). 2022 Oct.

Abstract

Background/objectives: Obesity is the main risk factor for obstructive sleep apnoea, commonly occurring in females who are overweight after menopause. We aimed to study the effect of a palaeolithic diet on sleep apnoea in females with overweight after menopause from the population.

Methods: Seventy healthy, non-smoking females with a mean age of 60 years and a mean BMI of 33 kg/m2 were randomised to a palaeolithic diet or to a control low-fat diet according to Nordic Nutritional Recommendations, for 2 years. The apnoea-hypopnoea index was measured and daytime sleepiness was estimated during the intervention.

Results: The mean apnoea-hypopnoea index at baseline was 11.6 (95% CI 8.6-14.5). The mean weight loss was 7.2 kg (95% CI 5.3-9.2 kg) in the palaeolithic diet group and 3.9 kg in the control group (95% CI 1.9-5.9 kg); p < 0.021 for the group difference. The reduction in weight corresponded to a reduction in the apnoea-hypopnoea index in the palaeolithic diet group (r = 0.38, p = 0.034) but not in the control group (r = 0.08, p = 0.69). The apnoea-hypopnoea index was reduced in the palaeolithic diet group when the weight was reduced by more than 8 kg. Daytime sleepiness according to the Epworth Sleepiness Scale score and the Karolinska Sleepiness Scale score was unaffected by dietary group allocation.

Conclusions: A substantial decrease in body weight of 8 kg was needed to achieve a reduction in sleep apnoea in this small trial of women who are overweight after menopause. The palaeolithic diet was more effective for weight reduction than a control low-fat diet and the reduction in sleep apnoea was related to the degree of weight decrement within this diet group.

Trial registration: Clinicaltrials.gov: NCT00692536.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Flow chart of participants in the study.
The inclusion of dropouts in the intention-to-treat analysis is noteworthy.
Fig. 2
Fig. 2. The association between weight loss in kg and change in the apnoea-hypopnoea index (AHI) in the two dietary groups.
A reduction in weight corresponded to a reduction in the apnoea-hypopnoea index in the palaeolithic diet group (r = 0.38, p = 0.034) but not in the control low-fat diet group (r = 0.08, p = 0.69). A decrease in the apnoea-hypopnoea index was mainly present in individuals with a weight reduction of more than 8 kg in the palaeolithic diet group.
Fig. 3
Fig. 3. The association between change in body mass index and change in the apnoea-hypopnoea index (AHI) in the two dietary groups.
A reduction in body mass index corresponded to a reduction in the apnoea-hypopnoea index in the palaeolithic diet group (r = 0.137, p = 0.037) but not in the control low-fat diet group (r = 0.005, p = 0.70).
Fig. 4
Fig. 4. Change in apnoea-hypopnoea index (AHI) and 8 kg weight loss.
The box plot illustrates the difference in the change in AHI between participants who lost ≥8 kg vs. <8 kg from baseline to follow-up after 2 years regardless of dietary intervention.

References

    1. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98. - PMC - PubMed
    1. Franklin KA, Sahlin C, Stenlund H, Lindberg E. Sleep apnoea is a common occurrence in females. Eur Respir J. 2013;41:610–5. - PubMed
    1. Zolfaghari S, Yao C, Thompson C, Gosselin N, Desautels A, Dang-Vu TT, et al. Effects of menopause on sleep quality and sleep disorders: Canadian Longitudinal Study on Aging. Menopause. 2020;27:295–304. - PubMed
    1. Perger E, Mattaliano P, Lombardi C. Menopause and Sleep Apnea. Maturitas. 2019;124:35–8. - PubMed
    1. Perger E, Pengo MF, Lombardi C. Hypertension and atrial fibrillation in obstructive sleep apnea: is it a menopause issue? Maturitas. 2019;124:32–4. - PubMed

Publication types

Associated data